These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3757391)

  • 21. Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.
    Palma-Aguirre JA; Rosas-Alcázar G; Rodríguez JM; León-Urrea F; Montoya-Cabrera MA
    Arch Invest Med (Mex); 1989; 20(2):129-35. PubMed ID: 2604495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nifedipine: kinetics and dynamics in healthy subjects.
    Kleinbloesem CH; van Brummelen P; van de Linde JA; Voogd PJ; Breimer DD
    Clin Pharmacol Ther; 1984 Jun; 35(6):742-9. PubMed ID: 6734025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unexpected haemodynamic instability associated with standard bicarbonate haemodialysis.
    Gabutti L; Ferrari N; Giudici G; Mombelli G; Marone C
    Nephrol Dial Transplant; 2003 Nov; 18(11):2369-76. PubMed ID: 14551368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nifedipine as an antihypertensive drug in patients with renal failure--pharmacokinetics and effects.
    Odar-Cederlöf I; Anderson P; Bondesson U
    J Intern Med; 1990 May; 227(5):329-37. PubMed ID: 2341826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceforanide pharmacokinetics in haemodialysis: the effect of ultrafiltration.
    Lanao JM; de Prada CR; Dominguez-Gil A; Tabernero JM; Martín J; Gómez JR
    Biopharm Drug Dispos; 1986; 7(4):335-46. PubMed ID: 3768489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis.
    Larsson R; Erlanson P; Bodemar G; Norlander B; Fransson L; Strouth L
    Eur J Clin Pharmacol; 1982; 21(4):325-30. PubMed ID: 7056278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic changes in right ventricular pressures during haemodialysis recorded with an implantable haemodynamic monitor.
    Braunschweig F; Kjellström B; Söderhäll M; Clyne N; Linde C
    Nephrol Dial Transplant; 2006 Jan; 21(1):176-83. PubMed ID: 16144845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.
    van Harten J; van Brummelen P; Zeegers RR; Danhof M; Breimer DD
    Br J Clin Pharmacol; 1988 Jun; 25(6):709-17. PubMed ID: 3203043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium ramping reduces hypotension and symptoms during haemodialysis.
    Tang HL; Wong SH; Chu KH; Lee W; Cheuk A; Tang CM; Kong IL; Fung KS; Tsang WK; Chan HW; Tong KL
    Hong Kong Med J; 2006 Feb; 12(1):10-4. PubMed ID: 16495583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels and possible haemodynamic effects following anorectal application of an ointment containing nifedipine and lignocaine : a study in healthy volunteers.
    Perrotti P; Grumetto L; Barbato F; Antropoli C
    Clin Drug Investig; 2006; 26(8):459-67. PubMed ID: 17163278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal function after cardiopulmonary bypass surgery in patients with impaired renal function. A randomized study of the effect of nifedipine.
    Witczak BJ; Hartmann A; Geiran OR; Bugge JF
    Eur J Anaesthesiol; 2008 Apr; 25(4):319-25. PubMed ID: 18182121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
    Attman PO; Ottosson P; Samuelsson O; Eriksson UG; Eriksson-Lepkowska M; Fager G
    Nephrol Dial Transplant; 2005 Sep; 20(9):1889-97. PubMed ID: 15928099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nifedipine. Relationship between pharmacokinetics and pharmacodynamics.
    Kleinbloesem CH; van Brummelen P; Breimer DD
    Clin Pharmacokinet; 1987 Jan; 12(1):12-29. PubMed ID: 3545614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis.
    Parasrampuria DA; Marbury T; Matsushima N; Chen S; Wickremasingha PK; He L; Dishy V; Brown KS
    Thromb Haemost; 2015 Apr; 113(4):719-27. PubMed ID: 25566930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of ofloxacin and adequacy of maintenance dose for patients on haemodialysis.
    Kampf D; Borner K; Pustelnik A
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():61-8. PubMed ID: 2286592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elimination of intravenously administered ibandronate in patients on haemodialysis: a monocentre open study.
    Bergner R; Dill K; Boerner D; Uppenkamp M
    Nephrol Dial Transplant; 2002 Jul; 17(7):1281-5. PubMed ID: 12105253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nifedipine serum concentration; effects upon blood pressure and heart rate in normotensive volunteers.
    Nakashima T; Inoki M; Nakanishi Y
    Eur J Drug Metab Pharmacokinet; 1984; 9(1):73-8. PubMed ID: 6714271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The haemodynamic effects of intravenous nifedipine in normotensive and hypertensive subjects.
    Walley TJ; Heagerty AM; Woods KL; Bing RF; Pohl JE; Barnett DB
    J Hum Hypertens; 1988 Oct; 2(3):199-202. PubMed ID: 3236324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients.
    Soldini D; Zwahlen H; Gabutti L; Marzo A; Marone C
    Eur J Clin Pharmacol; 2005 Feb; 60(12):859-64. PubMed ID: 15657783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.